2021
DOI: 10.3389/fgene.2021.760501
|View full text |Cite
|
Sign up to set email alerts
|

Network Biology Approaches to Achieve Precision Medicine in Inflammatory Bowel Disease

Abstract: Inflammatory bowel disease (IBD) is a chronic immune-mediated condition arising due to complex interactions between multiple genetic and environmental factors. Despite recent advances, the pathogenesis of the condition is not fully understood and patients still experience suboptimal clinical outcomes. Over the past few years, investigators are increasingly capturing multi-omics data from patient cohorts to better characterise the disease. However, reaching clinically translatable endpoints from these complex m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 134 publications
(166 reference statements)
0
11
0
1
Order By: Relevance
“…It is expected that the multi-omics method may be more robust in guiding the precise treatment of IBD and other complex diseases ( 71 , 72 ). With the exponential increase in the availability of molecular data utilized through omics technology, network biology could become a valuable tool for analyzing patient data from multiple omics to achieve the key goals of PM for IBD and other complex diseases ( 73 , 74 ). In addition, artificial intelligence, including machine learning and deep learning, could provide many potential solutions for the treatment of IBD ( 75 ).…”
Section: Discussionmentioning
confidence: 99%
“…It is expected that the multi-omics method may be more robust in guiding the precise treatment of IBD and other complex diseases ( 71 , 72 ). With the exponential increase in the availability of molecular data utilized through omics technology, network biology could become a valuable tool for analyzing patient data from multiple omics to achieve the key goals of PM for IBD and other complex diseases ( 73 , 74 ). In addition, artificial intelligence, including machine learning and deep learning, could provide many potential solutions for the treatment of IBD ( 75 ).…”
Section: Discussionmentioning
confidence: 99%
“…To enhance transparency and accessibility of bio-sample data, standardization and harmonization of data frameworks are needed at a global level. A Data Commons should be established to facilitate global collaboration and provide access to biospecimens and data before and after treatment with established and novel therapies[ 3 , 51 ].…”
Section: Precision Medicine To Predict Disease Susceptibility Diagnos...mentioning
confidence: 99%
“…The pathophysiology of ulcerative colitis (UC) and Crohn’s disease (CD) is increasingly evolving, mainly focusing on its genome, exposome, microbiome, immunome, and many other omics approaches. Thomas et al [ 3 ] noted that the development of IBD is attributed to an aberrant immune reaction resulting from intricate interactions among various genetic risk factors, imbalanced gut flora, and environmental influences. Unlike rare and clearly defined monogenic disorders, IBD arises from mutations in multiple genes rather than a single gene[ 3 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…With the exponential increase in the availability of disease-specific gene expression data, especially in complex diseases such as IBD [ 25 ], there are new opportunities to further investigate the role of miRNAs in disease pathogenesis. In the following section, we provide a technical summary describing the steps required to perform transcriptome-based miRNA-target gene analysis in complex disorders.…”
Section: Bioinformatics Approaches For Predicting Mirna Function In C...mentioning
confidence: 99%